Observation of feasibility for levofloxacin sequential therapy of urinary tract infection
Abstract
Objective To explore the clinical evaluation of levofloxacin for the sequential treatment of urinary tract infections.Methods Choosed 176 Patients with urinary tract infections from June 2010 to June 2011 in our hospital.The patients of observation group took levofloxacin sequential therapy;the control group with conventional intravenous levofloxacin.Results The difference of clinical efficacy between the two groups was not statistically significant(P0.05);the incidence rate of adverse reactions and the treatment costs of observation group were lower than control group,the differences were statistically significant(P 0.01).Conclusion Levofloxacin sequential treatment of urinary tract infections can obtain satisfactory clinical results,and clinical adverse reactions less,lower costs,it is worth to use in clinical practice.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.